Breaking News

Bend Research Receives EU GMP Certification

January 30, 2013

Allows for manufacture of clinical supplies and testing

Bend Research Inc. has received certification of compliance with EU GMP regulations. The certification was granted by Sweden’s Medical Products Agency (MPA) and covers the manufacture of clinical pharmaceutical supplies and testing of those supplies at the company’s GMP facilities.
 
“The strategic addition of this certification—combined with new capabilities such as high-potency spray-drying and future commercial spray-drying—strengthens Bend Research’s position as a preferred provider for oral solubilized, modified-release, inhalation, and many other dosage forms,” said Rod Ray, Bend Research chief executive officer. “We knew the EU’s quality standards were stringent, but we were confident that our operations met those high standards and were eager to demonstrate that to our customers.”

Related Contract Manufacturing:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks